Could brain cell implants ease Parkinson's? new trial begins

NCT ID NCT06753331

Recruiting now Disease control Sponsor: Sumitomo Pharma America, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests a cell therapy called DSP-1083, implanted directly into the brain, for people with Parkinson's disease. About 25 participants will either get the real implant or a sham surgery to see if it's safe and helps control symptoms. The goal is to replace damaged cells that produce dopamine, a chemical lost in Parkinson's.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DSP-1083 (a cell therapy implanted into the brain)
What this could lead to: If it works, this could point toward a new way to control Parkinson's symptoms by replacing damaged brain cells, potentially reducing the need for medication.
What could go wrong: This is an early Phase 1/2 trial with only 25 people, so it's mainly checking safety. The surgery carries risks like infection or brain swelling, and the cells may not work or could cause abnormal growth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE

Contacts and locations

Locations

New York Presbyterian Hospital-Columbia University Medical Center
RECRUITING

New York, New York, 10032, United States
University of Kentucky Medical Center
RECRUITING

Lexington, Kentucky, 40536, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.